4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000032
CEO bought 43,000 shares at an average $0.01 ($472)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-20 | Purchase : show line 1 in the form | +5,000 | $0.01 | $59 | 21,839,397 | D |
| 2019-05-20 | Purchase : show line 2 in the form | +1,000 | $0.01 | $11 | 21,840,397 | D |
| 2019-05-21 | Purchase : show line 3 in the form | +5,000 | $0.01 | $55 | 21,845,397 | D |
| 2019-05-21 | Purchase : show line 4 in the form | +10,000 | $0.01 | $110 | 21,855,397 | D |
| 2019-05-21 | Purchase : show line 5 in the form | +5,000 | $0.01 | $53 | 21,860,397 | D |
| 2019-05-21 | Purchase : show line 6 in the form | +5,000 | $0.01 | $55 | 21,865,397 | D |
| 2019-05-21 | Purchase : show line 7 in the form | +5,000 | $0.01 | $55 | 21,870,397 | D |
| 2019-05-21 | Purchase : show line 8 in the form | +5,000 | $0.01 | $54 | 21,875,397 | D |
| 2019-05-21 | Purchase : show line 9 in the form | +2,000 | $0.01 | $22 | 21,877,397 | D |
| Open-market purchases · 43,000 sh · avg $0.01 · $472 | ||||||
Loading xslF345X03/primary_doc.xml…